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   bjectives: To analyze the expression and distribution pattern of extracellular matrix components in pleomorphic adenomas
of the major and minor salivary glands and to compare the morphological findings of these tumors with the immunohistochemical
expression, considering the different types of stroma predominating in each case. Methods and Results: The expression of
tenascin (TN) and fibronectin (FN) was analyzed in 23 cases of pleomorphic adenomas, 11 major and 12 minor salivary gland
tumors, by the streptavidin-biotin method using anti-tenascin and anti-fibronectin antibodies. In addition, the
immunohistochemical results were correlated with the morphological findings of the lesions. All cases analyzed were
immunoreactive for the antibodies used. Fibronectin showed strong labeling in fibrous and chondroid stroma, while labeling
was weak in hyaline and myxoid stroma. Tenascin expression was more intense in fibrous and chondroid stroma and moderate
in hyaline and myxoid stroma.
Conclusions: No difference in the expression of these proteins was observed between major and minor salivary gland tumors.
Uniterms: Extracellular matrix; Fibronectin; Tenascin; Pleomorphic adenoma; Salivary gland neoplasia.
   bjetivo: Analisar a expressão e o padrão de distribuição de componentes da matriz extracelular em adenomas pleomórficos
de glândula salivar maior e menor e comparar os achados morfológicos destes tumores com a expressão imuno-histoquímica
considerando os diferentes tipos de estromas presentes em cada caso. Métodos e Resultados: A expressão da tenascina (TN)
e fibronectina (FN) foi analisada em 23 casos de adenomas pleomórficos, sendo 11 tumores em glândula salivar maior e 12 em
glândula salivar menor, utilizando-se o método da estreptoavidina-biotina para os anticorpos anti-tenascina e anti-fibronectina.
Os resultados imuno-histoquimicos foram correlacionados com os achados morfológicos das lesões. Todos os casos foram
imunorreativos para a fibronectina mostrando forte expressão nos estromas fibrosos e condróides, embora fraca marcação
tenha sido evidenciada nos estromas hialinos e mixóides. A expressão da tenascina foi mais intensa nos estromas condróides
e fibrosos, sendo moderada nos estromas hialino e mixóide. Conclusões: Não houve diferença na expressão destas proteínas
entre os tumores de glândula salivar maior e menor.
Unitermos: Matriz extracelular; Fibronectina; Tenascina; Adenoma pleomórfico;Neoplasia de glândula salivar.
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INTRODUCTION
Pleomorphic adenoma is the most common benign
neoplasia of the salivary glands and is distinguished by its
cytomorphological and architectural diversity. Pleomorphic
adenomas consist of two types of cells, i.e., luminal and
non-luminal cells, and contain a variable stroma that can be
of the hyaline, myxoid, chondroid or fibrous type.
Parenchymatous cells are arranged in nests, chains, sheets
or in duct-like structures within these different types of
stroma3,6,13. The marked stromal variety observed in this
neoplasia results from factors such as the quantity and
distribution of proteins of the matrix produced by epithelial
and myoepithelial tumor cells, corresponding to the myxoid,
chondroid and hyaline areas4.
The extracellular matrix (ECM) plays an important role in
the regulation of cell behavior and in embryogenesis, wound
healing and tumor growth due to variations in its composition
and functioning in different tissues5. This matrix acts as a
support mechanism and cell anchor, participates in the
compartmentalization of the tissue into reservoirs for
substances produced by the cells, influences the regulation
of gene expression, mediates cell binding, and participates
in the filtration of salts and small molecules. Among the
matrix components, fibronectin and tenascin represent
predominantly adhesive fibrous proteins, which play a
fundamental role in the signaling process between cells and
in the control of the activity of other secreted proteins such
as growth factors, proteases and protease inhibitors1.
Several studies have been carried out to analyze the
expression of ECM components in different pathological
conditions, with emphasis on investigations analyzing
fibronectin and tenascin11,12,14,15,16,17. Some investigators have
emphasized the importance of the interaction between
pleomorphic adenoma neoplastic cells and matrix
components such as fibronectin and tenascin14,16, which
led others to suggest that these interactions influence the
variable morphological picture observed in this tumor11.
Based on the assumption that salivary gland neoplasias
tumor cells are able to modify the ECM through the lysis or
synthesis of matrix components, or even by promoting
desmoplasia, the purposes of this study were to analyze the
expression and distribution pattern of tenascin and
fibronectin in pleomorphic adenomas of the major and minor
salivary glands, and to compare the morphological findings
of these lesions to the immunohistochemical expression of
tenascin and fibronectin, considering the types of stroma
predominating in each case.
MATERIAL AND METHODS
Twenty-three paraffin-embedded pleomorphic adenoma
specimens, 11 major and 12 minor salivary gland tumors,
were obtained from the files of the Anatomical Pathology
Service of the Department of Oral Pathology, Dental School,
Federal University of Rio Grande do Norte (UFRN), and of
the Laboratory of Medical Pathology. The study was
approved by UFRN’s Research Ethics Committee.
Morphological analysis was performed on hematoxylin/
eosin-stained slides stored in the above files. For
immunohistochemical analysis, 3-µm thick sections were
obtained from tissue specimens fixed in 10% formalin and
embedded in paraffin. The sections were mounted on glass
slides previously treated with organosilane (3-
aminopropyltriethoxy-silane; Sigma Chemical Co., St. Louis,
MO, USA) adhesive and labeled by the streptavidin-biotin
method using anti-tenascin (clone TN2, Dako, A/S
Corporation, 1:50, 18 h) and anti-fibronectin (clone, A-245,
Dako, A/S Corporation, 1:500, 2 h) antibodies. Antigen was
recovered with 0.4% pepsin in an incubator at 37oC for 30
min and with 1% pepsin at 37oC for 1 h, respectively. The
sections were then incubated with 0.03% diaminobenzidine
(Sigma) chromogen solution and counterstained with
Mayer’s hematoxylin.
The expression and distribution of tenascin and
fibronectin were analyzed in each case under light
microscopy using the following parameters:
immunoreactivity, location and labeling pattern (intense,
moderate, weak, or absent). This analysis was performed by
two experienced pathologists.
RESULTS
Microscopically, the 11 major salivary gland tumors were
characterized by the presence of polygonal cells arranged
in sheets, chains, nests and duct-like structures whose
lumen, in some cases, contained eosinophilic material, with
a double cell layer being observed in most cases.
Myoepithelial cells, present in smaller numbers, showed
mainly a spindle-shaped and plasmocytoid aspect and were
characterized by a round morphology, eccentric nucleus and
hyalinized eosinophilic cytoplasm. The stroma of these
lesions was of the hyaline, myxoid, chondroid and fibrous
types, although in some cases a predominance of one
stromal type over the others was noted (Table 1).
The 12 cases of pleomorphic adenoma of the minor
salivary glands were characterized by epithelial cells
arranged in nests, sheets and duct-like structures. The cell
type was either epithelial or myoepithelial, with the latter
cell type showing a plasmocytoid or spindle-shaped
morphology, or even appearing as clear cells. The presence
of a double cell layer was sometimes noted in the duct-like
structures. The stroma was of the fibrous, hyaline, myxoid
and chondroid types (Table 1).
All cases analyzed were positive for fibronectin and
tenascin, although the intensity of immunolabeling varied
between specimens.
Tenascin
In the 11 cases of pleomorphic adenoma of the major
salivary glands, tenascin labeling was intense in 4 specimens
(36.4%), moderate in 6 (54.5%) and weak in 1(9.1%) (Table
2). The most intense labeling was observed in chondroid
and fibrous stromal areas. Labeling was also intense in areas
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surrounding parenchymatous epithelial nests (Figure 1A).
With respect to the 12 cases of pleomorphic adenoma of the
minor salivary glands, tenascin labeling was intense in 5
cases (41.7%), moderate in 3 (25%) and weak in 4 (33.3%).
The highest tenascin expression was observed in fibrous
and chondroid stromal areas (Table 2; Figure 1B).
Fibronectin
Regarding the pleomorphic adenoma of the major
salivary glands, fibronectin labeling was intense in 5
specimens (45.4%), moderate in 4 (36.4%) and weak in 2
(18.2%), the highest immunoreactivity being observed in
fibrous stroma, in areas adjacent to chondroid stroma,
around cell nests in the basement membrane region, and in
the fibrous capsule (Table 2; Figure 1C).
Regarding the pleomorphic adenoma of the minor
salivary glands, fibronectin expression was intense in 5
specimens (41.6%), moderate in 4 (33.3%) and weak in 3
(25%). Intense labeling was observed in fibrous stroma,
adjacent to chondroid areas, around epithelial nests, and in
the fibrous capsule (Table 2; Figure 1D).
DISCUSSION
Pleomorphic adenoma is the most frequent neoplasia
found in both major and minor salivary glands3,7,10 ,
corresponding to 60% of all tumors of these organs. In the
present study, microscopic analysis of the lesions showed
the classical cytomorphological and architectural
characteristics, with some variations according to the
affected gland analyzed. In pleomorphic adenomas of the
major salivary glands, the myoepithelial cells were mainly of
the spindle-shaped type, while a predominance of
plasmocytoid cells was observed in minor gland lesions in
more than half of the cases, findings that are commonly
reported by others3,13. Another interesting finding was the
fact that in major gland tumors the stromal component was
more abundant, with chondroid areas being observed in a
large number of cases, while in minor salivary gland lesions
the formation of this stromal type was observed in only one
case.
The complex composition that characterizes salivary
gland neoplasias is attributed to the myoepithelial
components of these tissues. Lam9, analyzing pleomorphic
adenomas by histochemistry and electron microscopy,
showed that the modified myoepithelial cell represents the
cellular source of stromal matrix since it develops the ability
Location N     Stromal types
 Hyaline  Fibrous Mixoid     Chondroid
n % n % n % n %
Major salivary Parotid 9 6 54.5 6 54.5 9 81.8 5 45.5
gland Submandibular 2 1 9.1 2 18.2 2 18.2 1 9.1
Total 11 7 63.3 8 72.7 11 100.0 6 54.5
Minor salivary Palate 7 6 50.0 6 50.0 6 50.0 - -
gland Lip 2 1 8.3 2 16.6 1 8.3 - -
Buccal Mucosa 1 1 8.3 - - 1 8.3 - -
Fornix 2 1 8.3 1 8.3 2 16.6 1 8.3
Total 12 9 75.0 9 75.0 10 83.3 1 8.3
TABLE 1- Morphological pattern of the stroma of pleomorphic adenomas of the major and minor salivary glands
N= number of cases per location. n= number of cases per stromal type
Figure 1(A)- Pleomorphic adenoma in major salivary gland.
Immunostaining for tenascin in the chondroid stroma
(streptavidin-biotin complex; original magnification X200);
(B). Minor salivary gland. Positive staining for tenascin in
the fibrous stroma (streptavidin-biotin complex; original
magnification X200); (C). Major salivary gland. Strong
expression for fibronectin in the fibrous stroma and around
polygonal cells nests (streptavidin-biotin complex; original
magnification X200);(D). Minor salivary gland. Strong
expression for fibronectin around epithelial cells nests and
adjacent to the chondroid area (streptavidin-biotin complex;
original magnification X200)
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to synthesize glycosaminoglycans and proteoglycans. As
a result, cells separate from each other and rupture the
basement membrane that wraps duct-myoepithelial cell units,
thus permitting the migration and dispersal of these cells to
the extracellular space. As a consequence of this, the stroma
transforms into the myxoid type. Raitz et al14, also stated
that myoepithelial cells lose their immunophenotype and
acquire new characteristics.
In the present study, all specimens showed positive
labeling, although of variable intensity, for anti-fibronectin
and anti-tenascin antibodies. Soini, et al.16 and Sherestha,
et al.15 suggested that the tenascin expression observed in
the stroma of pleomorphic adenomas, mainly in chondroid
areas, might be the result of a possible induction of
chondrogenic differentiation because this protein plays a
role in this differentiation process during embryogenesis.
Thus, the fact that tenascin resumes this role in tumor
development might explains the immunolabeling observed
in the present study around chondroid areas.
Our results are similar to those reported by Sunardhi-
Widyaputra and Van Damme 17 who observed a strong
fibronectin expression around chondroid stroma, and to
those reported by Luo, et al.11 who detected a strong
expression in chondroid, hyaline and myxoid areas. However,
these findings are in contrast to those reported by Raitz, et
al.14, who observed a higher fibronectin expression in
hyaline stroma, even though we obtained similar results to
theirs regarding fibronectin labeling in myxoid stromal areas
in which the expression of this protein was weak.
Analysis of the immunohistochemical results obtained
for tenascin showed moderate to intense expression in
almost all cases of major salivary gland tumors (90.9%), while
weak labeling was observed in only one case (9.1%). The
strongest expression was detected in chondroid and fibrous
stroma, as well as around neoplastic cell nests.
Tenascin expression in minor salivary gland tumors
showed an equal distribution of intense, moderate and weak
labeling, being intense in 5 cases, moderate in 3 and weak in
4. The strongest expression of this protein was observed in
fibrous and chondroid stroma (because these lesions are
highly cellularized), resembling the embryonic stage of
normal salivary glands in which tenascin plays an active
role as reported by Alberts, et al.1
According to Nakamura, et al.12, referring to the
chondroid areas of pleomorphic adenoma, tenascin also
plays a role in tumor development and remodeling. In
contrast, Shrestha, et al.15 defended the participation of
tenascin in embryogenesis, especially in areas of
chondrocyte differentiation. These facts perfectly explain
the stronger expression of tenascin in chondroid areas as
observed in all cases of the present study irrespective of
the gland involved, and also confirm the role of
neoplastically transformed myoepithelial cells in the
formation of these chondroid areas as a result of
glycosaminoglycan synthesis by these cells, as showed in
several studies4,16,17.
Other authors16,17 have suggested that the epithelial cells
of pleomorphic adenomas release tenascin and secrete
glycosaminoglycans, mainly hyaluronic acid and chondroitin
sulfate, which accumulate between cells isolating them from
the matrix. This fact might explain the labeling observed in
the present study in areas around epithelial nests. In addition,
glycosaminoglycans organize the ECM due to their ability
to interact with chondroitin sulfate, fibronectin and other
cells present in the stroma. These glycosaminoglycans have
affinity for tenascin which, therefore, might play a role in
ECM structural organization, as well as in epithelial-
mesenchymal interactions and in the production of myxoid
and chondroid stroma.
Some studies have already demonstrated the interaction
between cells and ECM components. For example, Jaeger,
et al.8 observed in vitro that the most undifferentiated cells
of pleomorphic adenomas differentiate into luminal or
neoplastic myoepithelial cells when in contact with the ECM.
In this respect, ECM proteins play an important role in the
development of neoplasias which, in turn, start to produce
their own ECM. Castilho2, studying the expression of CD44
and hyaluronic acid in pleomorphic adenomas, reported that
the presence of this acid in these lesions might facilitate cell
adhesion to ECM components, thus promoting neoplastic
Location    Intensity of expression number of cases (%) Total
    +++     ++       +
Major salivary gland 4 (36.4) 6 (54.5) 1 (9.1) 11 (100)
Tenascin
Minor salivary gland 5 (41.7) 3 (25) 4 (33.3) 12 (100)
Major salivary gland 5 (45.4) 4 (36.4) 2 (18.2) 11 (100)
Fibronectin
Minor salivary gland 5 (41.6) 4 (33.3) 3 (25) 12 (100)
TABLE 2- Intensity of expression of tenascin and fibronectin in pleomorphic adenomas of the major and minor salivary
glands
(+++) intense, (++) moderate, (+) weak.
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growth.
Based on the above considerations, it should be
emphasized the role of tenascin not only in the formation of
normal tissues, as demonstrated by many authors, but also
in the tumorigenesis process during which tenascin acquires
importance in growth and differentiation, in addition to being
involved in epithelial-mesenchymal interactions. In
pleomorphic adenomas, these interactions play an important
role in cell growth and differentiation, particularly in the
production of myxoid and chondroid matrix frequently
observed in the stroma of these tumors.
CONCLUSIONS
It may be concluded that fibronectin and tenascin are
both expressed in pleomorphic adenomas, although tenascin
shows a higher expression in all types of stroma present in
pleomorphic adenomas of both major and minor salivary
glands.
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